Tilray Brands, Inc.
TLRY Nasdaq· Medicinal Chemicals & Botanical Products
Last close · Oct 27, 2026
$2.77
KIRA · Stoqly’s AI analyst, in plain words
- Tilray Brands, Inc. had $915M of revenue in fiscal 2026, up 11.5% on the year before. Over five years, revenue changed +84.2% a year on average.
- Its operating margin was −6.9%, up 271.1 pts: of every 100 in sales, about −7 is left after running the business.
- Tilray Brands, Inc. lost $121M in fiscal 2026.
- Tilray Brands, Inc. owes $22.7M more than it holds in cash.
Market cap
$369M
P/E
—
Revenue
$915M
Net income
−$121M
Free cash flow
—
Operating margin
−6.9%
Tilray Brands, Inc. in 30 seconds · fiscal 2026
Are sales growing?
+11.5%
Yes. Sales grew 11.5% last year.
Does it make a profit?
−13.3%
No. It lost money last year.
How healthy are the accounts?
2 / 9
Weak. It passes 2 of 9 health tests.
How is the share priced?
—
No P/E: it made no profit over the last four quarters.
What Tilray Brands, Inc. does
No business description yet.
- Fiscal year ends
- May 31, 2026
- Latest annual report
- 10-K · Jul 28, 2026
- Legal name
- Tilray Brands, Inc.
- CIK
- 0001731348
Tilray Brands, Inc. · TLRY
Results and finances
The last 5 fiscal years. Amounts in USD.
| Fiscal year | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Sales and profit | |||||
| Revenue | $628M | $627M | $789M | $821M | $915M |
| Revenue growth | 1,356.9% | −0.2% | 25.8% | 4.1% | 11.5% |
| Gross margin | 18.6% | 23.4% | 28.3% | 29.3% | 28.4% |
| Operating margin | −97.1% | −218.4% | −22.1% | −277.9% | −6.9% |
| Net income | −$477M | −$1.5B | −$245M | −$2.2B | −$121M |
| Net margin | −75.9% | −231.6% | −31.1% | −266.3% | −13.3% |
| Diluted EPS | −$0.99 | −$2.35 | −$3.30 | −$24.56 | −$1.09 |
| Cash | |||||
| Cash from operations | −$177M | $7.9M | −$30.9M | −$94.6M | −$69.1M |
| Capital expenditure | $34.1M | $20.8M | $29.2M | $32.9M | — |
| Free cash flow | −$211M | −$12.9M | −$60.2M | −$128M | — |
| FCF margin | −33.6% | −2.1% | −7.6% | −15.5% | — |
| Share count change | 479.7% | 28.4% | −88.0% | 19.9% | 25.6% |
| Debt and strength | |||||
| Cash and short-term investments | $416M | $449M | $261M | $256M | $231M |
| Debt incl. finance leases | $204M | $23.4M | $63.1M | $53.0M | $254M |
| Shareholders' equity | $4.4B | $3.3B | $3.4B | $1.5B | $1.6B |
| Current ratio | 2.9x | 1.8x | 2.3x | 2.5x | 2.2x |
| Interest coverage | −15.4x | −29.4x | −3.5x | −55.2x | −2.1x |
| Returns and quality | |||||
| Return on capital | −11.5% | −37.4% | −4.3% | −142.9% | −3.3% |
| Return on equity | −10.8% | −37.7% | −7.2% | −88.3% | −7.8% |
| Return on tangible equity | −99.4% | −436.1% | −47.2% | −296.4% | −14.8% |
| Piotroski F-score | 3 | 5 | 7 | 5 | 2 |
| Altman Z'' | 3.9 | 0.1 | 2.9 | −11.0 | −3.6 |
Insiders bought, 12 months
$0.1M
3 insiders
Insiders sold, 12 months
$0.2M
1 insider
Of sales under plans
0%
$0.0M
How to read these numbers
- Revenue:
- Total sales reported in the income statement.
- Operating margin:
- Operating income as a share of revenue.
- Net income:
- Profit after all expenses, interest and tax.
- Free cash flow:
- Cash from operations minus capital spending.
- Net debt / EBITDA:
- Years of EBITDA needed to pay off net debt. Below zero means more cash than debt.
- Return on capital:
- After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Tilray Brands, Inc. · TLRY
Charts and comparison
Ten years at a glance, and how it stacks up against similar companies.
Revenue
Net income
Margins, % of revenue
Cash vs debt (incl. leases)
Free cash flow
Dividends and buybacks
KIRA
At $2.77 a share, the company is worth $369M.
Source: SEC EDGAR XBRL filings (CIK 0001731348). Data updated October 24, 2026. For information only — not investment advice. Check the original filings before relying on any figure.